{"id":690103,"date":"2022-09-29T06:57:01","date_gmt":"2022-09-29T10:57:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/"},"modified":"2022-09-29T06:57:01","modified_gmt":"2022-09-29T10:57:01","slug":"fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/","title":{"rendered":"Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia"},"content":{"rendered":"

<\/p>\n

Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia<\/b><\/p>\n

IRVING, Texas–(BUSINESS WIRE<\/a>)–Fluor Corporation<\/a> (NYSE: FLR) announced today that the company has been selected by a leading biologics company to perform procurement and construction management for a large-scale biologics drug substance manufacturing facility located in Scandinavia. Fluor will book the multi-hundred-million-dollar reimbursable contract value in the third quarter of 2022.\n<\/p>\n

\nThe facility will produce new capacity for advanced biologics that are used in a variety of treatments including vaccines, oncology and quality-of-life medicines. Fluor has performed the planning and enabling work for this project, and construction is now underway with the facility scheduled to be operational by 2025.\n<\/p>\n

\nFluor\u2019s Advanced Technologies & Life Sciences business is leading the project including support from its Nordic Technology Hub in Copenhagen, Denmark.\n<\/p>\n

About Fluor Corporation<\/span><\/b><\/p>\n

Fluor Corporation<\/a> (NYSE: FLR) is building a better future by applying world-class expertise to solve its clients\u2019 greatest challenges. Fluor\u2019s 41,000 employees provide professional and technical solutions that deliver safe, well-executed, capital-efficient projects to clients around the world. Fluor had revenue of $12.4 billion in 2021 and is ranked 259 among the Fortune 500 companies. With headquarters in Irving, Texas, Fluor has provided engineering, procurement and construction services for more than 110 years. For more information, please visit www.fluor.com<\/a> or follow Fluor on Twitter<\/a>, LinkedIn<\/a>, Facebook<\/a> and YouTube<\/a>.\n<\/p>\n

\n#atls\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20220929005118\/en\/<\/a><\/span><\/p>\n

\nBrian Mershon
\n
Media Relations
\n
469.398.7621\n<\/p>\n

\nJason Landkamer
\n
Investor Relations
\n
469.398.7222\n<\/p>\n

KEYWORDS:<\/b> Texas Sweden United States Finland North America Europe Denmark Norway<\/p>\n

INDUSTRY KEYWORDS:<\/b> Architecture Commercial Building & Real Estate Construction & Property Biotechnology Health Engineering Other Construction & Property Manufacturing<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia IRVING, Texas–(BUSINESS WIRE)–Fluor Corporation (NYSE: FLR) announced today that the company has been selected by a leading biologics company to perform procurement and construction management for a large-scale biologics drug substance manufacturing facility located in Scandinavia. Fluor will book the multi-hundred-million-dollar reimbursable contract value in the third quarter of 2022. The facility will produce new capacity for advanced biologics that are used in a variety of treatments including vaccines, oncology and quality-of-life medicines. Fluor has performed the planning and enabling work for this project, and construction is now underway with the facility scheduled to be operational by 2025. Fluor\u2019s Advanced Technologies & Life Sciences business is leading the project … <\/p>\n

Continue reading “Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-690103","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nFluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia IRVING, Texas–(BUSINESS WIRE)–Fluor Corporation (NYSE: FLR) announced today that the company has been selected by a leading biologics company to perform procurement and construction management for a large-scale biologics drug substance manufacturing facility located in Scandinavia. Fluor will book the multi-hundred-million-dollar reimbursable contract value in the third quarter of 2022. The facility will produce new capacity for advanced biologics that are used in a variety of treatments including vaccines, oncology and quality-of-life medicines. Fluor has performed the planning and enabling work for this project, and construction is now underway with the facility scheduled to be operational by 2025. Fluor\u2019s Advanced Technologies & Life Sciences business is leading the project … Continue reading "Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-29T10:57:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20220929005118r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia\",\"datePublished\":\"2022-09-29T10:57:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\\\/\"},\"wordCount\":284,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20220929005118r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\\\/\",\"name\":\"Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20220929005118r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2022-09-29T10:57:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20220929005118r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20220929005118r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/","og_locale":"en_US","og_type":"article","og_title":"Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia - Market Newsdesk","og_description":"Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia IRVING, Texas–(BUSINESS WIRE)–Fluor Corporation (NYSE: FLR) announced today that the company has been selected by a leading biologics company to perform procurement and construction management for a large-scale biologics drug substance manufacturing facility located in Scandinavia. Fluor will book the multi-hundred-million-dollar reimbursable contract value in the third quarter of 2022. The facility will produce new capacity for advanced biologics that are used in a variety of treatments including vaccines, oncology and quality-of-life medicines. Fluor has performed the planning and enabling work for this project, and construction is now underway with the facility scheduled to be operational by 2025. Fluor\u2019s Advanced Technologies & Life Sciences business is leading the project … Continue reading \"Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-29T10:57:01+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20220929005118r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia","datePublished":"2022-09-29T10:57:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/"},"wordCount":284,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20220929005118r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/","name":"Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20220929005118r1&sid=flmnd&distro=nx&lang=en","datePublished":"2022-09-29T10:57:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20220929005118r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20220929005118r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fluor-selected-for-expansion-of-large-scale-biologics-manufacturing-facility-in-scandinavia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Fluor Selected for Expansion of Large-Scale Biologics Manufacturing Facility in Scandinavia"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/690103","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=690103"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/690103\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=690103"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=690103"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=690103"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}